SCHEMBL29800682

SCHEMBL29800682

CCc1ccc2c(c1)Oc1cc(CC)ccc1C(=O)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
MAPT P10636 7/20 0.45
ALDH1A1 P00352 6/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
PARP1 P09874 1/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 3/20 0.42
ABL1 P00519 1/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 2/20 0.40
MITF O75030 1/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
CHEK1 O14757 1/20 0.39
TGM2 P21980 1/20 0.39
S1PR4 O95977 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23242561 0.93 ALDH1A1 (0.49) SMN1; SMN2MAPTALDH1A1L3MBTL1TDP1
SCHEMBL30811612 0.83 PARP1 (0.45) SMN1; SMN2MAPTALDH1A1L3MBTL1PARP1
SCHEMBL27344505 0.83 PARP1 (0.45) SMN1; SMN2MAPTALDH1A1L3MBTL1PARP1
SCHEMBL29800317 0.81 LMNA (0.46) SMN1; SMN2MAPTALDH1A1L3MBTL1TDP1
SCHEMBL23242534 0.81 LMNA (0.46) SMN1; SMN2MAPTALDH1A1L3MBTL1TDP1
SCHEMBL23242549 0.79 MAPT (0.56) SMN1; SMN2MAPTALDH1A1L3MBTL1TDP1
SCHEMBL13071140 0.77 PARP1 (0.51) SMN1; SMN2ALDH1A1PARP1ABL1KDM4E
SCHEMBL23242598 0.76 MAPT (0.48) MAPTALDH1A1L3MBTL1TDP1POLB
SCHEMBL31191639 0.76 ALOX5 (0.59) ALDH1A1PARP1KDM4EGAAHPGD
SCHEMBL5327486 0.75 MAOA (0.63) SMN1; SMN2MAPTALDH1A1L3MBTL1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929688-A 3- (4- (11H-dibenzo [ b, e ] [1,4] azepin-6-yl) piperazin-1-yl) -and 3- (4- (dibenzo [ b, f ] [1,4] oxazepin/thiazepin/diazepin-11-yl) piperazin-1-yl) -propionic acid derivatives as H1 and 5-HT 2A-receptor modulators for the treatment of sleep disorders 阿莱瑞恩公司 2022-08-19 CN disclosed